TTRX — Turn Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00Annual balance sheet for Turn Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | R2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 2.1 | 1.18 | 0.873 | 5.08 |
| Prepaid Expenses | ||||
| Total Current Assets | 2.13 | 1.2 | 1.1 | 5.2 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 0.081 | 0.033 | 0.12 | 0.079 |
| Net Intangible Assets | ||||
| Other Long Term Assets | ||||
| Total Assets | 2.91 | 2.01 | 2.05 | 12.2 |
| Payable / Accrued | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 1.72 | 0.49 | 0.708 | 6 |
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 1.76 | 1.93 | 2.23 | 7.48 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 1.16 | 0.086 | -0.177 | 4.69 |
| Total Liabilities & Shareholders' Equity | 2.91 | 2.01 | 2.05 | 12.2 |
| Total Common Shares Outstanding |